In a recent study, treatment with anti-VEGF antibody was found to normalize vascularization, decrease hypoxia and reduce granuloma size in a rabbit model of pulmonary TB, supporting a functional role for this molecule in TB pathogenesis [44]. Here, VEGFA is linked to tuberculosis.